|
Status |
Public on Dec 06, 2017 |
Title |
BRD4_IP_DMSO |
Sample type |
SRA |
|
|
Source name |
GM15850 LCLs (FRDA)
|
Organism |
Homo sapiens |
Characteristics |
antibody: BRD4 cell line: GM15850 LCLs (FRDA) treatment: 0.1% DMSO treatment time: 24 h
|
Treatment protocol |
GM15850 cells were treated with the indicated molecules for 24 h
|
Growth protocol |
RPMI 1640 Medium with 2 mM L-glutamine and 15% FBS
|
Extracted molecule |
genomic DNA |
Extraction protocol |
Cells were chemically crosslinked by the addition of 4 mL of 1.5% formaldehyde in PBS per 10 cm2 dish for 15 min at room temperature. Cells were resusupended in Lysis Buffer 1 (50 mM HEPES , pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% IGEPAL, 0.25% Triton X-100, 1X HALT protease inhibitor) and 3T3 mouse embryonic fibroblast cells (formaldehyde fixed as above) equivalent to 10% GM15850 cells were added to each sample for downstream ChIP-RX analysis. NGS libraries were generated with Thruplex DNAseq Single Index Kit (Rubicon) and sequenced (single end, 150 bp reads) via NextSeq 500.
|
|
|
Library strategy |
ChIP-Seq |
Library source |
genomic |
Library selection |
ChIP |
Instrument model |
Illumina NextSeq 500 |
|
|
Data processing |
n/a Genome_build: Human: GRCh37 (hg19) Mouse: mm9
|
|
|
Submission date |
May 30, 2017 |
Last update date |
May 15, 2019 |
Contact name |
Aseem Ansari |
Organization name |
University of Wisconsin-Madison
|
Department |
Biochemistry and The Genome Center
|
Lab |
Ansari
|
Street address |
440 Henry Mall
|
City |
Madison |
State/province |
WI |
ZIP/Postal code |
53706 |
Country |
USA |
|
|
Platform ID |
GPL18573 |
Series (2) |
GSE99402 |
ChIP-RX of GM15850 cells treated with synthetic transcription elongation factors |
GSE99403 |
Synthetic transcription elongation factors |
|
Relations |
BioSample |
SAMN07176164 |
SRA |
SRX2867630 |